Integrated Two-Analyte Population Pharmacokinetics Model of Patritumab Deruxtecan (HER3-DXd) Monotherapy in Patients with Solid Tumors.
Saved in:
| Title: | Integrated Two-Analyte Population Pharmacokinetics Model of Patritumab Deruxtecan (HER3-DXd) Monotherapy in Patients with Solid Tumors. |
|---|---|
| Authors: | Xu Y; Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA. yuan.xu@daiichisankyo.com., Lee M; Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA., Joshi R; Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA., Wang X; Metrum Research Group, Boston, Massachusetts, USA., Husband H; Metrum Research Group, Boston, Massachusetts, USA., Byrne R; Metrum Research Group, Boston, Massachusetts, USA., Waterhouse T; Metrum Research Group, Boston, Massachusetts, USA., Abutarif M; Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA., Vaddady P; Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA., Garimella T; Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA., Li L; Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA. |
| Source: | Clinical pharmacokinetics [Clin Pharmacokinet] 2025 Jun; Vol. 64 (6), pp. 943-957. Date of Electronic Publication: 2025 May 23. |
| Publication Type: | Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
